BioCentury
ARTICLE | Company News

Cumberland Pharmaceuticals Inc sales and marketing update

October 3, 2016 7:00 AM UTC

Cumberland launched Ethyol amifostine in the U.S. to treat xerostomia in postoperative radiation of head and neck cancer and cumulative renal toxicity in ovarian cancer patients. In May, Cumberland a...